Talphera (TLPH) Competitors

Aadi Bioscience (NASDAQ:AADI) and Talphera (NASDAQ:TLPH) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, community ranking, media sentiment and institutional ownership.

Do insiders & institutionals believe in AADI or TLPH?

52.1% of Aadi Bioscience shares are owned by institutional investors. Comparatively, 37.7% of Talphera shares are owned by institutional investors. 37.3% of Aadi Bioscience shares are owned by insiders. Comparatively, 3.2% of Talphera shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Which has better valuation & earnings, AADI or TLPH?

Talphera has lower revenue, but higher earnings than Aadi Bioscience. Talphera is trading at a lower price-to-earnings ratio than Aadi Bioscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aadi Bioscience	$25.07M	1.96	-$65.76M	-$2.35	-0.85
Talphera	$27K	384.24	-$18.40M	-$0.45	-1.12

Does the MarketBeat Community favor AADI or TLPH?

Aadi Bioscience received 1 more outperform votes than Talphera when rated by MarketBeat users. However, 100.00% of users gave Talphera an outperform vote while only 39.29% of users gave Aadi Bioscience an outperform vote.

Company	Underperform	Outperform
Aadi Bioscience	Outperform Votes 11 39.29%	Underperform Votes 17 60.71%
Talphera	Outperform Votes 10 100.00%	Underperform Votes No Votes

Does the media refer more to AADI or TLPH?

In the previous week, Talphera had 1 more articles in the media than Aadi Bioscience. MarketBeat recorded 3 mentions for Talphera and 2 mentions for Aadi Bioscience. Talphera's average media sentiment score of 0.65 beat Aadi Bioscience's score of -0.47 indicating that Talphera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aadi Bioscience	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Talphera	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, AADI or TLPH?

Aadi Bioscience has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, Talphera has a beta of -0.15, indicating that its share price is 115% less volatile than the S&P 500.

Do analysts rate AADI or TLPH?

Aadi Bioscience presently has a consensus price target of $1.67, suggesting a potential downside of 16.25%. Talphera has a consensus price target of $5.00, suggesting a potential upside of 888.14%. Given Talphera's stronger consensus rating and higher probable upside, analysts plainly believe Talphera is more favorable than Aadi Bioscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aadi Bioscience	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Talphera	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.50

Is AADI or TLPH more profitable?

Talphera has a net margin of 0.00% compared to Aadi Bioscience's net margin of -246.06%. Aadi Bioscience's return on equity of -71.87% beat Talphera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aadi Bioscience	-246.06%	-71.87%	-57.28%
Talphera	N/A	-118.46%	-65.82%

Summary

Talphera beats Aadi Bioscience on 12 of the 19 factors compared between the two stocks.